comparemela.com

Shares of Bausch + Lomb Co. (NYSE:BLCO – Get Free Report) have been assigned a consensus recommendation of “Moderate Buy” from the ten research firms that are covering the firm, Marketbeat.com reports. Five investment analysts have rated the stock with a hold recommendation and five have assigned a buy recommendation to the company. The average […]

Related Keywords

Canada , ,Barclays Plc ,Lomb Corporation ,Tower Research Capital ,Morgan Stanley ,Lomb Co ,Ophthalmic Pharmaceuticals ,Citigroup ,Barclays ,Royal Bank ,Harbor Capital Advisors Inc ,Get Free Report ,Funds Weigh In On Bausch ,Capital Advisors ,Lomb Stock ,Get Free ,Vision Care ,Lomb Daily ,Bausch Lomb ,Nyse Blco ,Blco ,Medical ,Ratings ,Consensus ,

© 2025 Vimarsana

comparemela.com © 2020. All Rights Reserved.